Prime Medicine, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $209 | $37,774 | $591 | $25,692 |
Gross Profit | 209 | 37,774 | -724 | 24,445 |
EBITDA | -52,674 | -54,134 | -47,026 | -53,296 |
EBIT | -54,232 | -55,672 | -48,341 | -54,543 |
Net Income | -52,518 | -55,327 | -45,761 | -65,643 |
Net Change In Cash | 209 | 37,774 | 591 | 25,692 |
Free Cash Flow | -27,189 | -47,393 | -70,031 | -45,704 |
Cash | 117,977 | 55,600 | 94,162 | 41,574 |
Basic Shares | 119,764 | 119,188 | 104,466 | 97,377 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $5,210 | $0 | $5,210 |
Gross Profit | -147,905 | -6,804 | -4,861 | 5,207 |
EBITDA | -193,759 | -110,755 | -160,992 | -889 |
EBIT | -198,412 | -122,769 | -165,853 | -932 |
Net Income | -198,133 | -121,821 | -165,367 | -3,410 |
Net Change In Cash | 0 | 5,210 | 0 | 5,210 |
Cost of Revenue | 2,571 | |||
Free Cash Flow | -174,136 | -147,922 | -38,232 | -6,183 |
Cash | 41,574 | 187,620 | 185,420 | 36,975 |
Basic Shares | 90,969 | 97,209 | 64,900 | 71,795 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.44 |
2024-06-30 | -$0.46 |
2024-03-31 | -$0.44 |
2023-12-31 | -$0.72 |
